Scott Kober discusses the clinical utility of syndromic infectious disease testing in the pediatric population.
Scott Kober sits down with Michael Edmund Watson, MD, PhD, clinical assistant professor of pediatric infectious disease, pediatrics, at University of Michigan Health in Ann Arbor, to discuss the clinical utility of syndromic infectious disease testing in the pediatric population.
Dupilumab safe, effective for up to 1 year for atopic dermatitis in infants, preschool children
May 3rd 2024According to new study data presented at the 2024 Pediatric Academic Societies Meeting, dupilumab (dupixent; Sanofi and Regeneron) demonstrated positive safety and efficacy results for up to 1 year in infants and preschool-age children with atopic dermatitis.